Dr. David Nutt, Prof. of Neuropsychopharmacology at Imperial College, pioneers breakthroughs from GABA to psychedelics.
Josh Hardman, founder of Psychedelic Alpha, offers data-driven insights on psychedelics, spanning business, policy, and research.
Dr. Julie Holland, NYT-bestselling psychiatrist and MAPS advisor, pioneers MDMA and cannabis-assisted therapies.
Dr. Dea Stenbæk researches psilocybin’s effects on the brain, focusing on serotonin, neurocognition, and therapeutic setting using PET imaging.
Dr. Paul Liknaitzky, leading psychedelic researcher at Monash, spearheads transformative clinical trials and novel therapies in Australia.
Psychologist and researcher in Zurich and Basel studying psychedelics; also practices PAT and trains therapists through the Swiss Medical Association.
Meet the speakers
Speakers headlining the Borealis Psychedelic Science Summit 2025 are renowned researchers, clinicians, and innovators at the forefront of psychedelic science. Each brings unique expertise, fresh insights, and a passion for shaping the future of mental healthcare. Explore their bios and what they’ll be sharing on our main stage.
Borealis Psychedelic Science Summit 2025
Borealis Psychedelic Science Summit 2025 is a Nordic conference focusing on the latest developments in psychedelic research and therapy. It will be held from September 26–27 at the Elite Hotel Marina Tower in Stockholm, bringing together researchers, clinicians, policymakers, and industry representatives worldwide. The event features presentations of evidence-based research, discussions on practical implementation, and an examination of ethical considerations related to psychedelic treatments.
Enhancing Psychedelic-Assisted Therapy with Acceptance and Commitment Therapy
Led by ACT researcher Jason Luoma, PhD, this full-day workshop at Elite Hotel Marina Tower teaches clinicians how to apply ACT’s six core processes, acceptance, defusion, present-moment awareness, self-as-context, values, and committed action, to the preparation, dosing, and integration phases of psilocybin, MDMA, and ketamine-assisted therapy.
Join us at
Elite Hotel Marina Tower
Experience the Borealis Psychedelic Science Summit 2025 at the Elite Hotel Marina Tower, perched elegantly on Stockholm’s waterfront. Just a short boat or bus ride from the city center, this four-star venue offers stunning sea views, modern comforts, and a tranquil spa, ideal for unwinding after a day of inspiring talks and networking.
Become a Partner
By supporting this landmark gathering of researchers, clinicians, and policymakers, you’ll demonstrate a commitment to advancing responsible, evidence-based therapies poised to transform healthcare. Partnership also offers elevated visibility across our channels, exclusive engagement with global thought leaders, and a powerful platform to showcase your organization’s vision.
